Under the agreement, AtlantiCare will retain its brand name and local autonomy, according to a news release. The partnership will focus on the implementation of evidence-based medicine, enhancing clinical services, optimizing the use of electronic health records and clinical informatics, implementing population health management and moving toward value-based payment models. Financial terms of the deal were not disclosed.
“It is an especially challenging time in healthcare; however, we stand at the brink of making significant enhancements that will benefit patients for generations to come,” Geisinger President and CEO Glenn Steele, Jr., MD, PhD, said in the release. “Today’s announcement is good news for the people we serve, and we look forward to making a positive difference in southern New Jersey.”
Geisinger and AtlantiCare originally signed a letter of intent this past November to partner. The proposed integration now moves on to the regulatory approval phase, which is expected to take 9 to 12 months.
More Articles on Health System Transactions:
6 Recent Hospital Transactions and Partnerships
Lahey Health, Winchester Hospital Expected to Finalize Affiliation by July
The Details of Hospital Transactions and Real Estate Deals: Q&A With VMG Health’s Frank Fehribach
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.